Home
KAPA
KAPA News

Latest KAIROS PHARMA LTD (KAPA) News on December 23, 2024

ACCESSWIRE

7 days ago

Kairos Pharma to Participate in The Microcap Conference in January 2025

Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial

Business Wire

20 days ago

Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial

Kairos Pharma Approved to Dual List on Upstream

GlobeNewswire

a month ago

Kairos Pharma Approved to Dual List on Upstream

GlobeNewswire

2 months ago

Kairos Pharma to Present at the LD Micro Main Event XVII

GlobeNewswire

2 months ago

Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire

3 months ago

Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients

GlobeNewswire

3 months ago

Kairos Pharma Closing of $6.2 Million Initial Public Offering

GlobeNewswire

3 months ago

Kairos Pharma Prices $6.2 Million Initial Public Offering

Share on Social Networks: